| Term 
 
        | Neuromuscular blocking agent |  | Definition 
 
        | blocks action of acetylcholine, does not affect cardiac muscle 
 relax or paralyze skeletal muscle, given IV, Surgery, ECT, ETT
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Neuromuscular Blocking Agent |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Neuromuscular Blocking Agent |  | 
        |  | 
        
        | Term 
 
        | Centrally Acting Skeletal Muscle Relaxants |  | Definition 
 
        | Treat: CP and arthritis, muscle spasms, MS, spinal cord injury |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Centrally Acting Skeletal Muscle Relaxant |  | 
        |  | 
        
        | Term 
 
        | Direct Acting Skeletal Muscle Relaxants |  | Definition 
 
        | Inhibits calcium release from the skeletal muscle |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | relaxes spastic muscle, *caution* hepatotoxicity |  | 
        |  | 
        
        | Term 
 
        | Skeletal Muscle Stimulants |  | Definition 
 
        | Inhibits the action of anticholinesterase |  | 
        |  | 
        
        | Term 
 
        | Corrects myasthenia gravis |  | Definition 
 
        | Skeletal Muscle Stimulant |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Skeletal muscle stimulant, long duration, better tolerated |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | characterized by < dopamine, GABA, Serotonin, Norepinephrine and > acetylcholine in the brain |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | anti-Parkinson agent; if pt cannot tolerate Levodopa |  | 
        |  | 
        
        | Term 
 
        | Carbidopa/Levodopa (Sinemet) |  | Definition 
 
        | reduces the required levadopa dose by 25% |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Catechol-O-Methyltransferase Inhibitors |  | Definition 
 
        | Anti-Parkinson drug NEWEST; sustains dopaminergic level |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | brief episode of abnormal electrical activity in the nerve cells |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Spasmodic contractions of involuntary muscles |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Barbiturate; sedation, hypnosis, resp depression |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | treat and prevent gen tonic-clonic & psychomotor seizures |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Hydantoin; anticonvulsant |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | absence seizure treatment |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Valium, Klonopin, Tranzene, Valproic acid, Carbamazepine (Tegretol) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | results from low ACh in the brain |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | increased salivation, diarrhea, cramping, bradycardia, miosis |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | contraction of the pupil of the eye |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | antioxidant properties, protects from neural injury |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  |